Next Article in Journal
An Experimental and Theoretical Study of the Optical Properties of (C2H7N4O)2BiCl5 for an Optoelectronic Application
Next Article in Special Issue
New Trends on Vanadium Chemistry, Biochemistry, and Medicinal Chemistry
Previous Article in Journal
Synergistic Effect of Co and Mn Co-Doping on SnO2 Lithium-Ion Anodes
Previous Article in Special Issue
Antioxidant and Anticancer Activities and Protein Interaction of the Oxidovanadium(IV) Naringin Complex
 
 
Review
Peer-Review Record

An Overview of Vanadium and Cell Signaling in Potential Cancer Treatments

Inorganics 2022, 10(4), 47; https://doi.org/10.3390/inorganics10040047
by Valeria Alejandra Ferretti 1 and Ignacio Esteban León 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Inorganics 2022, 10(4), 47; https://doi.org/10.3390/inorganics10040047
Submission received: 26 February 2022 / Revised: 28 March 2022 / Accepted: 29 March 2022 / Published: 1 April 2022

Round 1

Reviewer 1 Report

Comments to Authors
Vanadium is becoming increasingly important in the field of health and this review gives a good overview of the use of this element as an anticancer agent and the signaling pathways it has been shown to influence.
1. Title: The review is focused on the antitumor activity of vanadium, but I consider that the title is ambiguous in this regard, because it is understood as the role of vanadium as a carcinogenic agent. I suggest refining the title, as well as adding the word "Review".
2. Introduction: The abbreviation "VO-flavonoids" is not described in the text.
3. Section 3: Cancer-related signalling [...]: At the end of each sub-section I suggest that you add a short general explanation of the implications that vanadium would have on each pathway, so that the reader understands specifically: what does it imply that vanadium affects that signalling pathway?
4.    Sub-section 3.4. JAK-STAT the reference of Gonzalez-Villalba et al. should read Gonzalez-Villalva et al. as written in the references.
5.    It is important that the authors write the "Conclusion" of the review.
6.    Review the format of the references: references 8, 9, 10, 46 and 47 have only the authors' initials. Also, if the article is in an electronic journal, it is not necessary to put [internet] this format does not apply to this type of references. I suggest reviewing the style of the references. 

Author Response

Comments to Authors

Vanadium is becoming increasingly important in the field of health and this review gives a good overview of the use of this element as an anticancer agent and the signaling pathways it has been shown to influence.


We specially thank to the reviewer 1 for the constructive comments.


  1. Title: The review is focused on the antitumor activity of vanadium, but I consider that the title is ambiguous in this regard, because it is understood as the role of vanadium as a carcinogenic agent. I suggest refining the title, as well as adding the word "Review".


According to the reviewer´s comments we have been changed the title in the new version of the manuscript.

  1. Introduction: The abbreviation "VO-flavonoids" is not described in the text.

Done.


  1. Section 3: Cancer-related signalling [...]: At the end of each sub-section I suggest that you add a short general explanation of the implications that vanadium would have on each pathway, so that the reader understands specifically: what does it imply that vanadium affects that signalling pathway?

According to the reviewer´s suggestion we have been added a short explanation about vanadium implication in each pathway.


  1.    Sub-section 3.4. JAK-STAT the reference of Gonzalez-Villalba et al. should read Gonzalez-Villalva et al. as written in the references.

Done.


  1.    It is important that the authors write the "Conclusion" of the review.

According to the reviewer´s comments we have been added a conclusion.


  1.    Review the format of the references: references 8, 9, 10, 46 and 47 have only the authors' initials. Also, if the article is in an electronic journal, it is not necessary to put [internet] this format does not apply to this type of references. I suggest reviewing the style of the references. 

Done.

Reviewer 2 Report

The authors provide a brief overview of the potentiality of vanadium (vanadate and complex vanadium compounds) in the treatment of diverse forms of cancer. The article is of general interest, and I recommend publication, subject to a couple of clarifications (see comments below), and amendment of the English throughout.

Comments:

1) Abstract: Vanadium is not only present in plants and animals, but also in, e.g., algae and bacteria.

2) p. 2, about centre: The statement “related to phosphate reactions in studies performed in cell-free systems” lacks clarity.

3) p. 3, line 2: NaVO3 does not exist in aqueous media.

4) p. 3, 3rd paragraph: “The vanadium is …” should read “Vanadium compounds are …”?

5) p. 3, end of 3rd paragraph: The last sentence in this paragraph lacks clarity.

6) p. 4, about centre: “glucose consumption” connotes “glucose degradation”?

7) p. 6, CDDP ?

9) p. 7, about centre: The statement “vanadium-cliochinol has exhibited dual behaviour …” lacks clarity.

10) p. 8, line 6: The actually active agent at physiological conditions in H2VO4- (and not sodium metavanadate).

11) p. 8, section 4.2: What is “a pro-death role” supposed to connote?

12) p. 9: [VO (bpy)2 Cl] Cl is [VO(bpy)2Cl]Cl (bpy = bipyridyl)?

Author Response

The authors provide a brief overview of the potentiality of vanadium (vanadate and complex vanadium compounds) in the treatment of diverse forms of cancer. The article is of general interest, and I recommend publication, subject to a couple of clarifications (see comments below), and amendment of the English throughout.


We specially thank to the reviewer 2 for the constructive comments.

 

 

 

Comments:

1) Abstract: Vanadium is not only present in plants and animals, but also in, e.g., algae and bacteria.

According to the reviewer´s comments we have added this information in the abstract section in the new version of manuscript.

2) p. 2, about centre: The statement “related to phosphate reactions in studies performed in cell-free systems” lacks clarity.

According to the reviewer´s comments we have changed this phrase in the new version of manuscript.

3) p. 3, line 2: NaVO3 does not exist in aqueous media.

Done

4) p. 3, 3rd paragraph: “The vanadium is …” should read “Vanadium compounds are …”?

Done

5) p. 3, end of 3rd paragraph: The last sentence in this paragraph lacks clarity.

According to the reviewer´s comments we have changed this sentence in the new version of manuscript.

6) p. 4, about centre: “glucose consumption” connotes “glucose degradation”?

Done

7) p. 6, CDDP ? 

CDDP= cisplatin.

Please, see the section 1 Introduction

9) p. 7, about centre: The statement “vanadium-cliochinol has exhibited dual behaviour …” lacks clarity.

According to the reviewer´s comments we have changed this sentence in the new version of manuscript.

10) p. 8, line 6: The actually active agent at physiological conditions in H2VO4- (and not sodium metavanadate).

Done.

11) p. 8, section 4.2: What is “a pro-death role” supposed to connote?

A pro-death role connotes that inducing and promotes cell death.

12) p. 9: [VO (bpy)2 Cl] Cl is [VO(bpy)2Cl]Cl (bpy = bipyridyl)?  

Done

Back to TopTop